QUADRANT CAPITAL GROUP LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 167 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$48,931
-27.0%
5,081
-19.4%
0.01%
-28.6%
Q2 2023$67,043
-4.8%
6,301
-5.9%
0.01%0.0%
Q1 2023$70,453
+95.9%
6,697
+130.8%
0.01%
+75.0%
Q4 2022$35,956
-7.8%
2,902
-23.0%
0.00%
-20.0%
Q3 2022$39,000
+1850.0%
3,768
+2065.5%
0.01%
Q2 2022$2,000174
+357.9%
0.00%
Q1 2022$038
+72.7%
0.00%
Q4 2021$0
-100.0%
22
-78.4%
0.00%
Q3 2021$1,000
-50.0%
102
-22.1%
0.00%
Q2 2021$2,0000.0%131
-15.5%
0.00%
Q1 2021$2,000
+100.0%
155
+106.7%
0.00%
Q4 2020$1,000
-85.7%
75
-86.6%
0.00%
-100.0%
Q4 2019$7,000
+75.0%
5580.0%0.00%0.0%
Q3 2019$4,000
-33.3%
5580.0%0.00%0.0%
Q2 2019$6,000
-14.3%
5580.0%0.00%0.0%
Q1 2019$7,000
+40.0%
5580.0%0.00%0.0%
Q4 2018$5,000
-50.0%
5580.0%0.00%
-66.7%
Q3 2018$10,0000.0%5580.0%0.00%
-25.0%
Q2 2018$10,000
+25.0%
5580.0%0.00%
+33.3%
Q1 2018$8,0000.0%5580.0%0.00%0.0%
Q4 2017$8,0000.0%5580.0%0.00%0.0%
Q3 2017$8,000
-20.0%
5580.0%0.00%
-25.0%
Q2 2017$10,000
+11.1%
5580.0%0.00%0.0%
Q1 2017$9,000
+12.5%
5580.0%0.00%0.0%
Q4 2016$8,0000.0%5580.0%0.00%
-20.0%
Q3 2016$8,000
+14.3%
5580.0%0.01%0.0%
Q2 2016$7,000
+16.7%
5580.0%0.01%
+25.0%
Q1 2016$6,0005580.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders